A Quantitative Lung Mucin Score to Identify Chronic Bronchitis
The MUCQ metric was superior in distinguishing patients with CB compared to a total mucin concentration. Trials are needed to ascertain the prospective use of MUCQ metrics in research and clinical settings for assessment, management, and tracking therapeutic responses in CB and potentially other muco-obstructive conditions. (Funded by the National Institutes of Health and others.).
Authors
- Christopher B. Cooper
- Eugene R. Bleecker
- Fernando J. Martinez
- Stephanie A. Christenson
- Richard E. Kanner
- R. Graham Barr
- Eric A. Hoffman
- MeiLan K. Han
- Prescott G. Woodruff
- Giorgia Radicioni
- Annette T. Hastie
- Richard C. Boucher
- Mehmet Kesimer
- Neil E. Alexis
- Robert Paine
- Amina A. Ford
- Nadia N. Hansel
- Agathe Ceppe
Institutions
- University of North Carolina at Chapel Hill (US)
- UMass Memorial Health Care (US)
- University of Arizona (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- University of Massachusetts Chan Medical School (US)
- University of Utah (US)
- Columbia University Irving Medical Center (US)
- Johns Hopkins Medicine (US)
- University of Iowa Hospitals and Clinics (US)
- Lung Institute (US)
- University of California San Francisco Medical Center (US)
- Michigan Medicine (US)
- Wake Forest University (US)
- Columbia University (US)
Publication Details
- Journal
- NEJM Evidence
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1056/evidoa2500051
- Citations
- 1
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 36.44